Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Cytomedix, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Sheila Walcoff | 2006-07: Counselor to The Honorable Michael O. Leavitt (Immediate Office of the Secretary), U.S.Department of Health/Human Services; 2004-06: Assoc Commissioner for External Affairs, U.S. FDA; 1998-99: Majority Counsel, Armed Services Committee, U.S. House of Representatives |
| Neil Quinter | 1997-99: Minority Chief Counsel/Staff Director, Senate Subcommittee on Technology, Terrorism & Government Infor- mation, U.S. Senate; 1995-97, Counsel, Senator Dianne Feinstein 1997-99: Minority Chief Counsel./Staff Director, Senate Subcomm on Technology, Terrorism & Government Information; 1995-97: Counsel, Senator Dianne Feinstein. |
| Eric Zimmerman | n/a |
| Paul Radensky MD | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate